top of page


Cresemba Expansion Continues with Japan Launch
Basilea Pharmaceutica has announced that it has received a development-related milestone payment of CHF5m from its Japanese licensing...

Adam Strydom
Jan 18, 20241 min read
Â
Â
Â


Strong Execution Resulting in Operating Profitability
On the heels of management’s January upward guidance revision, continued strong execution of Basilea Pharmaceutica’s outlined strategic...

Adam Strydom
Jan 18, 20241 min read
Â
Â
Â


Cresemba Milestone Payment Triggered
Basilea Pharmaceutica has announced that it has received a sales-related milestone payment of CHF20m from its US licensing partner...

Adam Strydom
Jan 18, 20241 min read
Â
Â
Â


Third Leg of Strategy Executed With Debt Repayment
Basilea Pharmaceutica is focused on treating infectious diseases. Basilea has announced the full repayment of the CHF113.8m outstanding...

Adam Strydom
Jan 18, 20241 min read
Â
Â
Â
All
bottom of page